Michelle Lybeck

1.1k total citations · 1 hit paper
21 papers, 741 citations indexed

About

Michelle Lybeck is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michelle Lybeck has authored 21 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michelle Lybeck's work include Epigenetics and DNA Methylation (5 papers), Lung Cancer Research Studies (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Michelle Lybeck is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Lung Cancer Research Studies (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Michelle Lybeck collaborates with scholars based in United States, Finland and South Africa. Michelle Lybeck's co-authors include Bryan Oronsky, Arnold L. Oronsky, Tony R. Reid, Neil Oronsky, Scott Caroen, Christopher Larson, Terese Hammond, Santosh Kesari, Corey A. Carter and Pedro Cabrales and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer and Oncotarget.

In The Last Decade

Michelle Lybeck

21 papers receiving 718 citations

Hit Papers

A Review of Persistent Post-COVID Syndrome (PPCS) 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Review of Persistent Post-COVID Syndrome (PPCS)
    2021 269 citations Bryan Oronsky, Christopher Larson et al. Clinical Reviews in Allergy & Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Lybeck United States 12 208 195 183 172 102 21 741
William Ricketts United Kingdom 12 258 1.2× 95 0.5× 115 0.6× 88 0.5× 39 0.4× 36 630
Di Ye China 12 258 1.2× 65 0.3× 215 1.2× 104 0.6× 121 1.2× 20 615
Qin Lu China 16 181 0.9× 63 0.3× 179 1.0× 117 0.7× 98 1.0× 50 652
Yingfeng Lu China 16 392 1.9× 228 1.2× 66 0.4× 105 0.6× 369 3.6× 42 1.2k
Rongfen Gao China 13 223 1.1× 71 0.4× 49 0.3× 53 0.3× 121 1.2× 31 576
Shuang Bai China 18 214 1.0× 86 0.4× 113 0.6× 184 1.1× 100 1.0× 61 1.1k
Hongquan Guan China 11 280 1.3× 210 1.1× 44 0.2× 99 0.6× 334 3.3× 15 794
Masataka Nishiga Japan 14 418 2.0× 330 1.7× 92 0.5× 188 1.1× 562 5.5× 27 1.6k
Huiling Liu China 9 197 0.9× 154 0.8× 33 0.2× 140 0.8× 244 2.4× 21 673

Countries citing papers authored by Michelle Lybeck

Since Specialization
Citations

This map shows the geographic impact of Michelle Lybeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Lybeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Lybeck more than expected).

Fields of papers citing papers by Michelle Lybeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Lybeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Lybeck. The network helps show where Michelle Lybeck may publish in the future.

Co-authorship network of co-authors of Michelle Lybeck

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Lybeck. A scholar is included among the top collaborators of Michelle Lybeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Lybeck. Michelle Lybeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oronsky, Bryan, Scott Caroen, Michelle Lybeck, et al.. (2022). A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC). Journal of Cancer. 13(9). 2945–2953. 38 indexed citations
2.
Oronsky, Bryan, Christopher Larson, Terese Hammond, et al.. (2021). A Review of Persistent Post-COVID Syndrome (PPCS). Clinical Reviews in Allergy & Immunology. 64(1). 66–74. 269 indexed citations breakdown →
3.
Larson, Christopher, Bryan Oronsky, Sharad Goyal, et al.. (2020). COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(2). 188412–188412. 6 indexed citations
4.
Caroen, Scott, Bryan Oronsky, Corey Carter, et al.. (2020). Rationale and necessity for delivery of RRx-001, a Myc and CD47 antagonist, by intravenous blood mix. Expert Opinion on Drug Delivery. 17(6). 741–742. 7 indexed citations
5.
Oronsky, Bryan, Sharad Goyal, Michelle M. Kim, et al.. (2018). A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis. Translational Oncology. 11(3). 771–778. 75 indexed citations
6.
Brzezniak, Christina, Bryan Oronsky, Jane B. Trepel, et al.. (2017). RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor. Case Reports in Oncology. 10(1). 276–280. 6 indexed citations
7.
Oronsky, Bryan, Scott Caroen, Arnold L. Oronsky, et al.. (2017). Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management. Cancer Chemotherapy and Pharmacology. 80(5). 895–907. 72 indexed citations
8.
Oronsky, Bryan, Tony R. Reid, Pedro Cabrales, et al.. (2017). Navigating the “No Man's Land” of TKI-Failed EGFR-Mutated Non–Small Cell Lung Cancer (NSCLC): A Review. Neoplasia. 20(1). 92–98. 22 indexed citations
9.
Brzezniak, Christina, Patricia E. Hogan, Bryan Oronsky, et al.. (2017). A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic Syndrome. Case Reports in Oncology. 10(1). 321–324. 3 indexed citations
10.
Cabrales, Pedro, Scott Caroen, Arnold L. Oronsky, et al.. (2017). The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury. Expert Review of Hematology. 10(6). 575–582. 13 indexed citations
11.
Carter, Corey A., Bryan Oronsky, Joseph Roswarski, et al.. (2017). No patient left behind: The promise of immune priming with epigenetic agents. OncoImmunology. 6(10). e1315486–e1315486. 10 indexed citations
12.
Fens, Marcel H.A.M., Pedro Cabrales, Jan Scicinski, et al.. (2016). Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation. Medical Oncology. 33(8). 85–85. 10 indexed citations
13.
Carter, Corey A., Regina M. Day, Patrick Richard, et al.. (2016). Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies. Oncotarget. 7(26). 40781–40791. 6 indexed citations
14.
Oronsky, Bryan, Corey Carter, Arnold L. Oronsky, et al.. (2016). Medical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapy. Oncotarget. 7(8). 9041–9045. 5 indexed citations
15.
Oronsky, Bryan, Jan Scicinski, Michelle M. Kim, et al.. (2016). Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents. Biomolecules. 6(3). 32–32. 10 indexed citations
16.
Oronsky, Bryan, Arnold L. Oronsky, Michelle Lybeck, et al.. (2015). Episensitization: Defying Time’s Arrow. Frontiers in Oncology. 5. 134–134. 32 indexed citations
17.
Oronsky, Bryan, Corey A. Carter, Tony R. Reid, et al.. (2015). Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance. Neoplasia. 17(9). 716–722. 18 indexed citations
18.
Oronsky, Bryan, Corey A. Carter, Jan Scicinski, et al.. (2015). The War on Cancer: A Military Perspective. Frontiers in Oncology. 4. 387–387. 15 indexed citations
19.
Oronsky, Bryan, Neil Oronsky, Gary R. Fanger, et al.. (2014). Follow the ATP: Tumor Energy Production: A Perspective. Anti-Cancer Agents in Medicinal Chemistry. 14(9). 1187–1198. 66 indexed citations
20.
Oronsky, Bryan, Neil Oronsky, Jan Scicinski, et al.. (2014). Rewriting the Epigenetic Code for Tumor Resensitization: A Review. Translational Oncology. 7(5). 626–631. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Ricketts Breakdown of academic impact, for papers by Di Ye Breakdown of academic impact, for papers by Qin Lu Breakdown of academic impact, for papers by Yingfeng Lu Breakdown of academic impact, for papers by Rongfen Gao Breakdown of academic impact, for papers by Shuang Bai Breakdown of academic impact, for papers by Hongquan Guan Breakdown of academic impact, for papers by Masataka Nishiga Breakdown of academic impact, for papers by Huiling Liu
Rankless by CCL
2026